EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Characterising a New Sheep Model of Parkinson's Disease Using Unilateral Intracerebral Injection of 6‐Hydroxydopamine Into the Substantia Nigra

Ashik Banstola iD, Nicolas Vautrelle, David Bergin iD, Younus Mohammad, Kushan Gandhi iD, Shakila Rizwan iD, John N J Reynolds iD

European Journal of Neuroscience · 2025

DOI: 10.1111/ejn.16668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2025. Verfasst von Ashik Banstola und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Oxidopamine, Disease Models, Animal, Substantia Nigra, Parkinson Disease. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Neurological Foundation of New Zealand, Holdsworth Charitable Trust, Ministry of Business, Innovation and Employment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New therapeutic agents developed for treating neurological disorders are often tested successfully on rodents. Testing in an appropriate large animal model where there is longer lifespan and comparable brain size to humans should improve translational success and is frequently expected by regulatory bodies. In this project, we aimed to establish a novel sheep model of Parkinson's disease as a large‐brained experimental model for translational research. Our objective was to create a sheep model of Parkinson's disease by unilaterally infusing the neurotoxin 6‐hydroxydopamine into the substantia nigra pars compacta. This approach, previously used to induce parkinsonism in rat and non‐human primate models, causes dopaminergic imbalance and induces rotational behaviour in quadrupeds challenged with dopaminergic receptor agonists. In the present sheep study, the mixed dopamine receptor agonist apomorphine, 0.25 mg/kg, and dopamine D2 agonist ropinirole, 0.16 mg/kg, were used to induce rotational behaviour and confirm dopamine depletion. Behavioural signs were then measured and characterised in the field using automated movement tracking with simultaneous video recordings. Post‐mortem, the extent of the 6‐hydroxydopamine lesions was evaluated through tyrosine hydroxylase immunohistochemistry and quantifying levels of catecholamines (dopamine, 3,4‐dihydroxyphenylacetic acid and homovanilic acid) quantified using high‐performance liquid chromatography. Our new sheep model of Parkinson's disease using 6‐hydroxydopamine is safe and offers a number of regulatory, ethical and financial advantages over non‐human primate 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine models. It provides a platform to evaluate novel antiparkinsonian agents and medical devices in a large brain with the promise of greater success for translation into clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxidopamineDisease Models, AnimalSubstantia NigraParkinson DiseaseParkinsonian DisordersAnimalsApomorphineSheepDopamine AgonistsIndolesTyrosine 3-MonooxygenaseFemaleMaleDopamine

Stichwörter der Autor:innen

6‐hydroxydopamineParkinson's diseasedopamine agonistsmotor behavioursheep modelsubstantia nigra

Substanzen

OxidopamineApomorphineDopamine AgonistsropiniroleIndolesTyrosine 3-MonooxygenaseDopamine

Autor:innen und Institutionen

  • Department of Anatomy, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand.
  • Brain Health Research Centre, University of Otago, Dunedin, New Zealand.
  • School of Pharmacy, University of Otago, Dunedin, New Zealand.

ORCID-Profile: Ashik Banstola, David Bergin, Kushan Gandhi, Shakila Rizwan, John N J Reynolds

Förderung

  • Neurological Foundation of New Zealand
  • Holdsworth Charitable Trust
  • Ministry of Business, Innovation and Employment

Zitieren

APA

Banstola, A., Vautrelle, N., Bergin, D., Mohammad, Y., Gandhi, K., Rizwan, S., & Reynolds, J. N. J. (2025). Characterising a New Sheep Model of Parkinson's Disease Using Unilateral Intracerebral Injection of 6‐Hydroxydopamine Into the Substantia Nigra. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16668

Vancouver

Banstola A, Vautrelle N, Bergin D, Mohammad Y, Gandhi K, Rizwan S, et al. Characterising a New Sheep Model of Parkinson's Disease Using Unilateral Intracerebral Injection of 6‐Hydroxydopamine Into the Substantia Nigra. European Journal of Neuroscience. 2025. doi:10.1111/ejn.16668

BibTeX
@article{Banstola2025,
  author = {Banstola, Ashik and Vautrelle, Nicolas and Bergin, David and Mohammad, Younus and Gandhi, Kushan and Rizwan, Shakila and Reynolds, John N J},
  title = {Characterising a New Sheep Model of Parkinson's Disease Using Unilateral Intracerebral Injection of 6‐Hydroxydopamine Into the Substantia Nigra},
  journal = {European Journal of Neuroscience},
  year = {2025},
  doi = {10.1111/ejn.16668}
}
Kostenlos starten →